Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicineJosephine A. Taverna, Chun‐Liang Chen, Daniel T. DeArmond et al.|Lung Cancer|2024Cited by 21
The inhibition of ORMDL3 prevents Alzheimer's disease through ferroptosis by PERK/ATF4/HSPA5 pathwayYankun Shao, Lina Song|IET Nanobiotechnology|2023Cited by 15
<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineChia‐Nung Hung, Josephine A. Taverna, Maria Gaczyńska et al.|Preprints.org|2023Cited by 0